novo nordisk hims - Search News

News

Novo Nordisk Has Ended Its Wegovy Deal With Hims & Hers

Insider on MSN · 2d

Hims & Hers stock plunges after Novo Nordisk ends its brief partnership

The Danish pharmaceutical said it was ending the partnership because Hims is selling and promoting a cheaper copycat of its blockbuster drug Wegovy.

CNBC on MSN · 3d

Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 34%

Novo Nordisk said Hims & Hers has "failed to adhere to the law which prohibits mass sales of compounded drugs" under the "false guise" of personalization.

CBS News on MSN · 3d

Novo Nordisk halts Wegovy sales on Hims & Hers, claiming "deceptive marketing" practices

Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the weight-loss drug.

2d

Long Island experts weigh in after Novo Nordisk ends deal with Hims & Hers over weight loss meds

Novo Nordisk had been providing Hims & Hers with the FDA-approved Wegovy, an injectable semaglutide used for weight loss ...

4hon MSN

Novo Nordisk says WeightWatchers will sell Wegovy, announces $299 price

Novo Nordisk said on Thursday it will collaborate with WeightWatchers to sell its blockbuster weight-loss drug Wegovy, ...

2d

Hims & Hers: Devastating GLP-1 News Could Shatter Growth Narrative

Hims & Hers delivered record Q1 results and expanded into Europe with the Zava acquisition. Click here to see why HIMS stock ...

3d

Novo sends Hims packing

Meanwhile, Novo had agreed supply deals with Hims and several of its bigger rivals. The idea was to give their existing ...

3don MSN

Novo Nordisk shares fall as obesity pipeline faces investor scrutiny

Shares in Novo Nordisk fell as much as 3.5% on Monday after detailed trial data on its experimental obesity drug CagriSema ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results